Economists are reconsidering labour market forecasts due to rapid cuts in federal jobs by the Trump administration. Economics ...

Five-star-rated analyst Mark Mahaney at Evercore ISI has downgraded his rating from Buy to Hold on The Trade Desk (TTD) after the company reported mixed results for 2024. Mahaney also trimmed the ...

Morgan Stanley lowered the firm’s price target on Evercore (EVR) to $306 from $400 and keeps an Overweight rating on the shares. The robust ...

On Tuesday, Evercore ISI reaffirmed its In Line rating ... including the E.U., the United Kingdom (TADAWUL:4280), India, South Korea, and Australia. The company has been actively engaged with ...

CEO John Weinberg highlighted that 2024 was Evercore's second-best year for revenue, reaching over $3 billion in adjusted net revenues, with strength across all business segments. He noted the ...

In this article, we are going to take a look at where Evercore Inc. (NYSE:EVR) stands against other oversold financial stocks to buy right now. On March 7th, Federal Reserve Chairman Jerome Powell ...

Evercore ISI has upgraded CRISPR Therapeutics (NASDAQ:CRSP) to Outperform, citing multiple upcoming catalysts that could drive the stock higher. The firm is now factoring in CTX320 and CTX310 in ...

On Wednesday, Evercore ISI began coverage on Summit Therapeutics plc (NASDAQ:SMMT) shares, assigning an Outperform rating and setting a price target of $30.00. The $13.65 billion market cap ...